Dengue vaccine efficacy: Not a zero sum game

Journal of Infectious Diseases

Volumn 214, Issue 12, 2016, Pages 2014-

  Halstead, Scott B ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE;

DENGUE; DRUG EFFICACY; HUMAN; IMMUNOPRECIPITATION; INFECTION RESISTANCE; LETTER; OUTCOME ASSESSMENT; SENSITIZATION; VACCINATION; DENGUE VIRUS; IMMUNOLOGY;

DENGUE; DENGUE VACCINES; DENGUE VIRUS; HUMANS;

EID: 85016015412     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw458     Document Type: Letter

References (9)

1. Wilder-Smith A, Vannice KS, Hombach J, Farrar J, Nolan T. Population perspectives and World Health Organization recommendations for CYD-TDV dengue vaccine. J Infect Dis 2016; 214:1796-9.
2. Secretariat. Background paper on dengue vaccines, SAGE Working Group on Dengue Vaccine. Geneva: World Health Organization, 2016.
3. Guy B, Jackson N. Dengue vaccine: hypotheses to understand CYD-TDV-induced protection. Nat Rev Microbiol 2016; 14:45-54.
4. Hadinegoro SR, Arredondo-Garcia JL, Guy B, Bouckenooghe A, Noriega F, Jackson N. Answer to the review from Halstead and Russell Protective and immunological behavior of chimeric yellow fever dengue vaccine (DOI 10. 1016/j. vaccine. 2016. 02. 004). Vaccine 2016; 34:4273-4.
5. Halstead SB, Russell PK. Protective and immunological behavior of chimeric yellow fever dengue vaccine. Vaccine 2016; 34:1643-7.
6. Guzman MG, Kouri G, Bravo J, Valdes L, Vazquez S, Halstead SB. Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis 2002; 6:118-24.
7. Guzman MG, Kouri G, Valdes L, Bravo J, Vazquez S, Halstead SB. Enhanced severity of secondary dengue 2 infections occurring at an interval of 20 compared with 4 years after dengue 1 infection. PAHO J Epidemiol 2002; 81:223-7.
8. Fulginiti VA, Helfer RE. Atypical measles in adolescent siblings 16 years after killed measles virus vaccine. JAMA 1980; 244:804-6.
9. Anderson KB, Gibbons RV, Cummings DA, et al. A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand. J Infect Dis 2013; 209:360-8.